Biotech GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World’s First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal Dystrophy June 6, 2025
Biotech Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting June 5, 2025
Biotech Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities June 5, 2025
Biotech Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock June 4, 2025
Biotech Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board June 4, 2025
Biotech PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer June 3, 2025
Biotech Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million June 2, 2025
Biotech Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session June 1, 2025
Search
Biotech
June 6, 2025
June 5, 2025
June 5, 2025
June 4, 2025
June 4, 2025
June 3, 2025
June 3, 2025
June 2, 2025
June 2, 2025
June 1, 2025
